Effect of Turkish propolis extracts on proteome of prostate cancer cell line

Proteome Science

Volumn 9, Issue , 2011, Pages

  Barlak, Yaşam ^a   Deǧer, Orhan ^b   Çolak, Meltem ^a   Karatayli, Senem C ^c   Bozdayi, Abdurrahman M ^c   Yücesan, Fulya ^b  

^a GUMUSHANE UNIVERSITY   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Pc 3 prostate cancer cell line; Propolis; Proteome; SELDI TOF MS

Indexed keywords

ANTIOXIDANT; DIMETHYL SULFOXIDE; PHENOL DERIVATIVE; PROPOLIS; PROTEOME;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL VIABILITY; HUMAN; HUMAN CELL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 82755162471     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-9-74     Document Type: Article

References (40)

1. Santos FA, Bastos E, Maia A, Uzeda M, Carvalho M, Farias L, Moreira E. Brazilian propolis: physicochemical properties, plant origin and antibacterial activity on periodontopathogens. Phytothe Res 2003, 17:285-289.
2. Banskota A, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytother Res 2001, 15:561-571. 10.1002/ptr.1029, 11746834.
3. Burdock GA. Review of the biological properties and toxicity of bee propolis (Propolis). Food and Chem Toxicol 1998, 36:347-363.
4. Nakajima Y, Tsuruma K, Shimazawa M, Mishima S, Hideaki Hara H. Comparison of bee products based on assays of antioxidantcapacities. BMC Complement Altern Med 2009, 9:4. 10.1186/1472-6882-9-4, 2664783, 19243635.
5. Vi{dotless}uda-Martos M, Rui{dotless}z-Navajas Y, Fern'andez-L'opez J, P'erez-'Alvarez JA. Functional properties of honey, propolis and royal jelly. J Food Sci 2008, 73(9):116-124.
6. Tylkowski B, Trusheva B, Bankova V, Giamberini M, Peev G, Nikolova A. Corrigendum to "Extraction of biologically active compounds from Propolis and concentration of extract by nanofiltration". J Membr Sci 2010, 348:124-130.
7. Marcucci MC, Ferreres F, Garci{dotless}'a-Viguera C, Bankova VS, De Castro SL, Dantas AP, Valente PH, Paulino N. Phenolic compounds from Brazilian propolis with pharmacological activities. JEthnopharmacol 2001, 74:105-112.
8. Valente MJ, Baltazar AF, Henrique R, Estevinho L, Carvalho M. Biological activities of Portuguese propolis: Protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro. Food Chem Toxicol 2011, 49:86-92. 10.1016/j.fct.2010.10.001, 20934479.
9. Sforcin JM. Propolis and the immune system: a review. J Ethnopharmacol 2007, 113:1-14. 10.1016/j.jep.2007.05.012, 17580109.
10. Carballo DD, Malak S, Bardenheuer W, Freistuehler M, Reusch HP. The contribution of plukenetione A to the anti-tumoral activity of Cuban propolis. Bioorg Med Chem 2008, 16(22):9635-9643. 10.1016/j.bmc.2008.10.019, 18951805.
11. Park YK, Alencar SM, Agui{dotless}ar CL. Botanical origin and chemical composition of Brazilianpropolis. JAgric Food Chem 2002, 50:2502-2506.
12. Banskota AH, Nagaoka T, Sumioka LY, Tezuka Y, Awale S, Midorikawa K, Matsushige K, Kadota S. Antiproliferative activity of the Netherlands propolis and its active principles in cancer cell lines. J Ethnopharmacol 2002, 80:67-73. 10.1016/S0378-8741(02)00022-3, 11891088.
13. Clarke W, Zhang Z, Chan DW. The application of clinical proteomics to cancer and other diseases. Clin Chem Lab Med 2003, 41(12):1562-1570. 10.1515/CCLM.2003.239, 14708880.
14. Engwegen JYMN, Gast MCW, Schellens JHM, Beijnen JH. Clinical proteomics searching for beter tumour markers with SELDI_TOF mass spectrometry. Trends Pharmacol Sci 2006, 5(27):251-259.
15. Srinivas PR, Verma M, Zhao Y, Srivastava S. Proteomics for cancer biomarker discovery. Clin Chem 2002, 48(8):1160-1169.
16. Colantonio DA, Chan DW. The Clinical Application of Proteomics. Clin Chim Acta 2005, 357:151-158. 10.1016/j.cccn.2005.03.020, 15896729.
17. Zhang H, Kong B, Qu X, Jia L, Deng B, Yang Q. Biomarker discovery for ovarian cancer using SELDI-TOF-MS. Gynecol Oncol 2006, 102:61-66. 10.1016/j.ygyno.2005.11.029, 16403569.
18. Akashi T, Nishimura Y, Wakatabe R, Shiwa M, Yamori T. Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer. Biochem Biophys Res Commun 2007, 352:514-521. 10.1016/j.bbrc.2006.11.052, 17137555.
19. Woolley JF, Al-Rubeai M. The application of SELDI-TOF mass spectrometry to mammalian cell culture. Biotech Adv 2009, 2(27):177-184.
20. Szliszka E, Zydowicz G, Janoszka B, Dobosz C, Kowalczyk-Ziomek G, Krol W. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced. apoptosis Int J Onc 2011, 38:941-953.
21. Lee CH, Jeong SJ, Yun SM, Kim JH, Lee HJ, Ahn KS, Won SH, Kim HS, Lee HJ, Ahn KS, Zhu S, Chen CY, Kim SH. Down-regulation of phosphoglucomutase 3 mediates sulforaphane-induced cell death in LNCaP prostate cancer cells. Proteome Sci 2010, 8:67. 10.1186/1477-5956-8-67, 3024296, 21159204.
22. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HS, Kwast T, Wiegel T, Zattoni F. EAU Guidelines on ProstateCancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease. Eur Urol 2011, 59:61-71. 10.1016/j.eururo.2010.10.039, 21056534.
23. Syed DN, Suh Y, Afaq F, Mukhtar H. Dietary agents for chemoprevention of prostate cancer. Cancer Lett 2008, 265:167-176. 10.1016/j.canlet.2008.02.050, 3220618, 18395333.
24. Syed DN, Khan N, Afaq F, Mukhtar H. Chemoprevention of prostate cancer through dietary agents progress and promise. Cancer Epidemiol Biomarkers Prevent 2007, 16(11):2193-2203.
25. Orsolic N, Basic I. Water-soluble derivative of propolis and its polyphenolic compounds enhance tumoricidal activity of macrophages. J Ethnopharmacol 2005, 102:37-45. 10.1016/j.jep.2005.05.036, 16054317.
26. Tripathi YB, Tripathi P, Arjmandi AH. Nutraceuticals and cancer management. Front Biosci 2005, 10:1607-1618. 10.2741/1644, 15769650.
27. Mohammadzadeh S, Sharriatpanahi M, Hamedi M, Amanzadeh Y, Ebrahimi SES, Ostad SN. Antioxidant power of Iranian propolisextract. Food Chem 2007, 103:729-733.
28. Aliyazi{dotless}ci{dotless}oǧlu Y, Deǧer O, Ovali{dotless} E, Barlak Y, Hoşver I, Tekelioǧlu Y, Karahan SC. Effects of Turkish pollen and propolis extracts on respiratory burst for K-562 cell lines. Int Immunopharmacol 2005, 5:1652-1657. 10.1016/j.intimp.2005.04.005, 16039555.
29. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide pharmacological, cellular, and molecular aspects. Biochem Pharmacol 2003, 65:1035-1041. 10.1016/S0006-2952(03)00002-9, 12663039.
30. Russo A, Cardile V, Sanchez F, Troncoso N, Vanella A, Garbarino JA. Chilean propolis: antioxidant activity and antiproliferative action in human tumor cell lines. Life Sci 2004, 76:545-558. 10.1016/j.lfs.2004.07.019, 15556167.
31. Li H, Kapur A, Yang JX, Srivastava S, Mcleod DG, Guzman JFP, Daugsch A, Park YK, Rhim JS. Antiproliferation of human prostate cancer cells by ethanolic extracts of Brazilian propolis and its botanical origin. Int J Oncol 2007, 31:601-606.
32. Wang Z, Desmoulin S, Banerjee S, Kong D, Li Y, Deraniyagala RL, Abbruzzese J, Sarkar FH. Synergistic effects of multiple natural products in pancreatic cancer cells. Life Sci 2008, 83:293-300. 10.1016/j.lfs.2008.06.017, 2536622, 18640131.
33. Nair HK, Rao KVK, Aalinkeel R, Mahajan S, Chawda R, Schwartz SA. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol 2004, 1(11):63-69.
34. Cheng ZX, Liu BR, Qian XP, Ding YT, Hu WJ, Sun J, Yu LX. Proteomic analysis of anti-tumor effects by Rhizoma Paridistotalsaponin treatment in HepG2 cells. JEthnopharmacol 2008, 120:129-137.
35. Lee KW, Kang NJ, Kim JH, Lee KM, Lee DE, Hur HJ, Lee HJ. Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappaB. Genes Nutr 2008, 2:319-322. 10.1007/s12263-007-0067-9, 2478489, 18850224.
36. Bottoni P, Giardina B, Vitali A, Boninsegna A, Scatena R. A proteomic approach to characterizing ciglitazone-induced cancer cell differentiation in Hep-G2 cell line. Biochim Biophys Acta 2009, 1794:615-626.
37. Loti{dotless}to SB, Frei{dotless} B. Relevance of apple polyphenols as antioxidants in human plasma contrasting in vitro and in vivo effects. Free Radic Biol Med 2004, 36(2):201-211.
38. Erel T. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004, 37:277-285. 10.1016/j.clinbiochem.2003.11.015, 15003729.
39. Tsiapara AV, Jaakkola M, Chinou I, Graikou K, Tolonen T, Virtanen V, Moutsatsou P. Bioactivity of Greek honey extracts on breast cancer (MCF-7), prostate cancer (PC-3) and endometrial cancer (Ishikawa) cells profile analysis of extracts. Food Chem 2009, 116:702-708.
40. Nayler O, Schnorrer F, Stamm S, Ullrich A. The cellular localization of the murine serine/arginine-rich protein kinase CLK2 is regulated by serine 141 autophosphorylation. JBiol Chem 1998, 51(273):34341-34348.